Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Radiopharmaceuticals Market Is Growing At A CAGR Of 18.3% From 2013 To 2019. By Transparency Market Research.

Radiopharmaceuticals MarketRadiopharmaceuticals Market was valued at approximately USD 3.8 billion in 2013 and is expected to reach USD 12.2 billion by 2019 at a CAGR of 18.3% from 2013 to 2019. North America led the global radiopharmaceuticals market with the highest market share as Canada continues to be the largest exporter of uranium and nuclear technology, forming the backbone of nuclear medicine and imaging studies.

Browse the full report at

The market is expected to grow at a CAGR of 18.3% owing to tremendous research and technological developments occurring worldwide and the increasing awareness about nuclear medicine and molecular imaging procedures. The radiopharmaceuticals market is studied based on end-user groups, medical isotopes, applications and geography. Technetium (Tc-99m) is the most widely used radioisotope for medical applications. The majority of the application market for radiopharmaceuticals is constituted by the diagnosis market, and the therapeutic application segment is expected to grow at the fastest growth rate from 2012 to 2018.

The global market for generators for radiopharmaceuticals was valued at over USD 200 million in 2011 and is expected to grow at a healthy CAGR from 2012 to 2018. The market currently consists only of Tc-99m generators; newer generators for molecules like Rubidium (Rb-82), Gallium (Ga-67) and Yttrium (Y-90) are expected to enter the market in the next few years. These are expected to exhibit high double digit growth rates during the forecast period.

Key players in this market include Covidien Plc, Nordion Inc., Lantheus Medical Imaging and IBA Group, among others. The market is highly fragmented with leading global healthcare companies offering a wide range of diagnostic and therapeutic radiopharmaceuticals.

The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below:

Radiopharmaceuticals Market by Generator Types

Mo-99/Tc-99m generator

Sr-82/Rb-82 generator

Ge-68/Ga-68 generator

Sr-90/Y-90 generator

W-188/Re-188 generator

Radiopharmaceuticals Market by End-Users

Hospitals & Medical Centers

Diagnostic Centers

Radiopharmaceuticals Market by Applications


Diagnosis by Technique


Technetium (Tc-99m)

Thallium (TI-201)

Gallium (Ga-67)

Iodine (I-123)

Rhenium (Re-186)

Yttrium (Y-90)



Fludeoxyglucose (18F-FDG)

Rubidium (Rb-82)

Others (Carbon-11 choline, Nitrogen-13 ammonia)

Diagnosis by Indications



Others (Neurological, Thyroid, Gastrointestinal)


Systemic Oncology

Iodine (I-131)

Yttrium (90Y)

Samarium (Sm-153)

Strontium (89Sr)

Rhenium (186Re)

Lutetium (Lu-177)

Erbium (169Er)


Others (Cardiology, Neurology)

Radiopharmaceuticals Market by Geography

North America



Rest of the World (RoW)

For Sample Report Visit On:

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.